Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery Romain Zufferey 1 , Thomas Dull 2 , Ronald J. Mandel 2 , Anatoly Bukovsky 2 , Dulce Quiroz 2 , Luigi Naldini 2 , and Didier Trono 1 , * Department of Genetics and Microbiology, University of Geneva Medical School, Geneva, Switzerland, 1 and Cell Genesys, Foster City, California 2 ABSTRACT In vivo transduction of nondividing cells by human immunodeficiency virus type 1 (HIV-1)-based vectors results in transgene expression that is stable over several months. However, the use of HIV-1 vectors raises concerns about their safety. Here we describe a self-inactivating HIV-1 vector with a 400-nucleotide deletion in the 3′ long terminal repeat (LTR). The deletion, which includes the TATA box, abolished the LTR promoter activity but did not affect vector titers or transgene expression in vitro. The self-inactivating vector transduced neurons in vivo as efficiently as a vector with full-length LTRs. The inactivation design achieved in this work improves significantly the biosafety of HIV-derived vectors, as it reduces the likelihood that replication-competent retroviruses will originate in the vector producer and target cells, and hampers recombination with wild-type HIV in an infected host. Moreover, it improves the potential performance of the vector by removing LTR sequences previously associated with transcriptional interference and suppression in vivo and by allowing the construction of more-stringent tissue-specific or regulatable vectors. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Virology American Society For Microbiology

Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery

Journal of Virology , Volume 72 (12): 9873 – Dec 1, 1998

Abstract

Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery Romain Zufferey 1 , Thomas Dull 2 , Ronald J. Mandel 2 , Anatoly Bukovsky 2 , Dulce Quiroz 2 , Luigi Naldini 2 , and Didier Trono 1 , * Department of Genetics and Microbiology, University of Geneva Medical School, Geneva, Switzerland, 1 and Cell Genesys, Foster City, California 2 ABSTRACT In vivo transduction of nondividing cells by human immunodeficiency virus type 1 (HIV-1)-based vectors results in transgene expression that is stable over several months. However, the use of HIV-1 vectors raises concerns about their safety. Here we describe a self-inactivating HIV-1 vector with a 400-nucleotide deletion in the 3′ long terminal repeat (LTR). The deletion, which includes the TATA box, abolished the LTR promoter activity but did not affect vector titers or transgene expression in vitro. The self-inactivating vector transduced neurons in vivo as efficiently as a vector with full-length LTRs. The inactivation design achieved in this work improves significantly the biosafety of HIV-derived vectors, as it reduces the likelihood that replication-competent retroviruses will originate in the vector producer and target cells, and hampers recombination with wild-type HIV in an infected host. Moreover, it improves the potential performance of the vector by removing LTR sequences previously associated with transcriptional interference and suppression in vivo and by allowing the construction of more-stringent tissue-specific or regulatable vectors.

Loading next page...
 
/lp/american-society-for-microbiology/self-inactivating-lentivirus-vector-for-safe-and-efficient-in-vivo-VViOWSoD0s

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Society For Microbiology
Copyright
Copyright © 1998 by the American society for Microbiology.
ISSN
0022-538X
eISSN
1098-5514
Publisher site
See Article on Publisher Site

Abstract

Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery Romain Zufferey 1 , Thomas Dull 2 , Ronald J. Mandel 2 , Anatoly Bukovsky 2 , Dulce Quiroz 2 , Luigi Naldini 2 , and Didier Trono 1 , * Department of Genetics and Microbiology, University of Geneva Medical School, Geneva, Switzerland, 1 and Cell Genesys, Foster City, California 2 ABSTRACT In vivo transduction of nondividing cells by human immunodeficiency virus type 1 (HIV-1)-based vectors results in transgene expression that is stable over several months. However, the use of HIV-1 vectors raises concerns about their safety. Here we describe a self-inactivating HIV-1 vector with a 400-nucleotide deletion in the 3′ long terminal repeat (LTR). The deletion, which includes the TATA box, abolished the LTR promoter activity but did not affect vector titers or transgene expression in vitro. The self-inactivating vector transduced neurons in vivo as efficiently as a vector with full-length LTRs. The inactivation design achieved in this work improves significantly the biosafety of HIV-derived vectors, as it reduces the likelihood that replication-competent retroviruses will originate in the vector producer and target cells, and hampers recombination with wild-type HIV in an infected host. Moreover, it improves the potential performance of the vector by removing LTR sequences previously associated with transcriptional interference and suppression in vivo and by allowing the construction of more-stringent tissue-specific or regulatable vectors.

Journal

Journal of VirologyAmerican Society For Microbiology

Published: Dec 1, 1998

There are no references for this article.